Weekly etoposide, epirubicin, cisplatin, 5-fluorouracil and leucovorin: an effective chemotherapy in advanced gastric cancer.

In order to optimize the therapeutic index of combining etoposide, epirubicin, cisplatin, 5-fluorouracil (5-FU), leucovorin (EEPFL) chemotherapy in the treatment of advanced gastric cancer, a trial of a novel schedule of weekly administration was conducted. Weekly EEPFL treatment consisted of a conc...

Descripción completa

Detalles Bibliográficos
Autores principales: Chi, K. H., Chao, Y., Chan, W. K., Lo, S. S., Chen, S. Y., Yen, S. H., Chen, K. Y., Wu, C. W., Lee, S. D., Lui, W. Y.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1998
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150365/
https://www.ncbi.nlm.nih.gov/pubmed/9667679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2150365/
https://www.ncbi.nlm.nih.gov/pubmed/9667679

Ejemplares similares